Skip Navigation
  • The MHH
  • International office
  • Emergency numbers
  • Patients & Visitors
  • Facilities & Departments
    • Facilities & Departments
    • MHH Clinical departments
    • MHH-Institutes
    • Clinical departments and institutes sorted by center
    • Interdisciplinary centers
    • Central facilities
  • Research
    • Research
    • Research foci
      • Research foci
      • COVID-19
    • Core Research Units
      • Core Research Units
      • MeDIC
      • Hannover Unified Biobank (HUB)
      • Lasermikroskopie
      • Research Core Unit Electron Microscopy
    • Academic Career Development
    • Advisory Services
      • Advisory Services
      • DFG
    • Research Infrastructure
    • Dean of Research
    • Good Scientific Practice
      • Good Scientific Practice
      • Commission for Good Scientific Practice
      • Ombuds Office and Ombudsperson
    • Transparency in Research
    • Research Funding, Knowledge & Technology Transfer
      • Research Funding, Knowledge & Technology Transfer
      • Partners & Networks
      • For life scientists
      • For partners & investors
      • For startups and founders
  • Studying at MHH
    • Studying at MHH
    • All degree programs
    • Registrar's Office
      • Registrar's Office
      • Prospective students
      • Students
      • Dates & deadlines
      • Contact
  • Careers
Welcome to the MHH News
Searched for virology. Found 14 results in 3 Millisekunden.

Filter by:

  • All content
  • Common content
  • Ambulances
  • News
  • 1
  • 2
  • »
News

How cells defend themselves against adenoviruses

Relevance: 100%
 

Institute of Virology at the Technical University of Munich from Professor Schreiner's research group there. The team of authors also includes Dr Samuel Hofmann from the MHH Institute of Virology. Neither [...] against adenoviruses? The team of RESIST Professor Dr. Sabrina Schreiner from the Institute of Virology at the Hannover Medical School (MHH) has come a good deal closer to answering this question. The

News

Research for the weakest

Relevance: 90%
 

starting points for the development of drugs and vaccines, Professor Schreiner at the MHH Institute of Virology is investigating how the virus multiplies in the cell. Professor Dr Nico Lachmann's work also revolves [...] six institutions. RESIST spokesperson is Professor Dr Thomas Schulz, head of the MHH Institute of Virology. RESIST is funded by the German Research Foundation (DFG) from 2019 to 2025 with a total of around

News

A step on the way to better therapies against viruses

Relevance: 88%
 

does this. Now a team led by Dr Manutea Serrero and Professor Dr Beate Sodeik from the Institute of Virology at Hannover Medical School (MHH) has researched new findings on the interactions between MxB and [...] partner institutions. The spokesperson is Professor Dr Thomas Schulz, head of the MHH Institute of Virology. RESIST is funded by the German Research Foundation (DFG). For more information on the RESIST cluster

News

It's not just Corona: Infection research is about more

Relevance: 82%
 

partner institutions, the spokesperson is Professor Dr. Thomas Schulz, head of the MHH Institute of Virology. RESIST is funded by the German Research Foundation (DFG). SERVICE: Further information on RESIST

News

Prof. Dr. Christian Drosten guest at the MHH

Relevance: 80%
 

play during the COVID 19 pandemic - Professor Dr Christian Drosten, Director of the Institute of Virology at the Charité Mitte Campus of the University Medical Center Berlin since 2017. At the opening of

News

Fast & Reliable

Relevance: 77%
 

Zischke, for example, uses mass spectrometry. The postdoctoral researcher from the Institute of Virology is looking for new substances that are effective against the carcinogenic Kaposi Sarcoma Herpesvirus

News

MHH researchers elected to DFG review boards

Relevance: 72%
 

Christine Falk , Head of the Institute of Transplantation Immunology: Review Board Microbiology, Virology, Immunology, Subject 2.21-05 Immunology Professor Dr Frank Bengel , Director of the Clinic for Nuclear

News

Start: Biomedical Data Science

Relevance: 72%
 

the study programme together with you," said Prof. Dr. Thomas Schulz, head of the MHH Institute of Virology and spokesperson of the RESIST Cluster of Excellence, at the opening ceremony on 7 October. He is

News

Clever minds are given freedom to innovate

Relevance: 70%
 

spokesperson of the cluster of excellence is Professor Dr. Thomas Schulz, head of the MHH Institute of Virology. More information is available here: www.RESIST-cluster.de Further information is available to

News

Nutrients instead of antibiotics

Relevance: 70%
 

smallest detail. RESIST spokesperson is Professor Dr. Thomas Schulz, head of the MHH Institute of Virology. RESIST is funded by the German Research Foundation (DFG). For more information about the RESIST

  • 1
  • 2
  • »
Imprint Intranet Contact Privacy Accessibility
The MHH Hospital is a maximum care hospital with a nationwide catchment area. The university teaches medicine, dentistry, biochemistry, biomedicine, midwifery and health sciences. The main research areas are Transplantation and Stem Cell Research / Regenerative Medicine, Infection and Immunology Research, Biomedical Engineering and Implant Research.

   

Information about

Blood donation service MHH-Alumni e.V.

Follow us on

Facebook Instagram YouTube Xing LinkedIn
© 2019 - 2025 Medizinische Hochschule Hannover
Nach oben scrollen